Thank you for appreciating my post.
As for the reverse split?
We've been told it's been deemed necessary by the BOD so as to better reflect up and coming sister biotechs at least insofar as the prevailing share price is viewed.
Would I prefer that our shares find themselves being bid higher without the proposed reverse enactment? You bet! But I'm not on the board so it's not relevant.
The past few days I've been sensing that the reverse won't do nearly as much damage as earlier expected to be the case. I don't know why my attitude has changed but all any of us can do is trust our gut feelings built from instincts and knowledge. Since I don't know nuttin' and have a little more gut than I want, I'm stuck being stoopit! lol
As divulged previously on this board, I've been adding shares. My hunch is that I'm feeling safer somehow, now with a larger position. And that may be clouding my perspective, I don't know. Yet I'm also noticing that our shares are, in fact, demonstrating greater desirability visible via the increasing market pricing now at $6.27, well up from last night's $5.96.
So perhaps the negatives attached to Avita's post-reverse split marketability will prove to have been unfounded, at least in the real world? I have no way to know but it just seems sensible to me to make hay while the sun shines. And right now if I had what felt like an incomplete position in this stock, I'd be adding. After all, I doubt any of us think that sub-$11 is the eventual higher end we can expect to see RCEL shares worth.
There's a distancing I see in this stock at this time and really---in most all stocks under consideration by investors. We want guarantees of some sort. We may look to technical analysis, charts, maps, candlestick patterns and fundamentals handed down via press releases and SEC filings.
But in the end we make our investment decisions based on anything enabling us to "feel" the stock's worthiness.
Yesterday and today RCEL wasn't just murmuring sweet things in my ear. No, she was downright screaming at me to take the gift of cheap shares that may never again drop to today's buy points. So I moved on those yells. Everything in me insisted that I follow through.
So, then---the BOD'. made it clear the reverse is necessary in order to introduce this U.S. newly domiciled stock at a price comparable to others on the same medic-oriented stage. $30 or so was foisted as a good staging area.
Frankly I don't care. The number of shares I hold is meaningless so long as sufficient value is there to be seen and treasured. And I'm betting that those responsible for advising Avita's BOD have long recognized the possibility of a short attack. So?
Well, I've got an emergency cushion ready for deployment should our shares drop massively. But I'm hopeful that the BOD has reason to NOT expect a damaging period around the corner.
We shall see, my friend.
Good fortune, all!
